News on medical imaging technologies and applications.
The findings run counter to historical data and may provide fodder to reconsider current guideline recommendations on surveillance of colorectal cancer patients.
In a study, Medical Research Council scientists demonstrated that a test that uses flow cytometry and looks for the CD63 protein in mast cells had 98 percent specificity.
Participants in the financing round included CS Investors, Pivotal Paramount Investment, and Stanford University.
The team developed their method to facilitate tumor cell movement through the blood-brain barrier for cancer biomarker detection. The method could eventually lead to the detection of brain cancer using a blood test.
Their machine learning technology coupled with digital holography produced an 84 percent success rate in predicting canine responses to chemotherapy.
